Dedicated FDA staff guide companies during design of clinical trials
Pharma companies less likely to disclose critical drug information than public institutions
R&D outlays and patents alone don’t effectively measure corporate creativity
Sales forecasting improves markedly as firms participate in standard setting organizations
Backers like to offer suggestions to a not-quite-finished product
Researchers aim to help the agency, drug companies and patients better understand the complex authorization process
Field researchers constructed a model to subsidize essential goods for low-income communities in crisis, and profit in recovery